Scientists hunt for molecules that predict spinal cord healing

NCT ID NCT07383077

Completed Knowledge-focused Sponsor: Prof. Sandra Vieira Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study analyzed blood and other samples from 106 adults with recent spinal cord injuries to find molecules linked to better recovery. Researchers measured changes in these molecules before and after rehabilitation and one year after injury. The goal is to identify biological clues that could lead to new treatments for spinal cord injury.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify biological markers that help predict recovery after spinal cord injury, potentially pointing toward new drug targets.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear biomarkers, and any identified candidates would need years of further testing before becoming therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL CORD INJURY

Contacts and locations

Locations

Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho, E.P.E. (ULSGE), Vila Nova de Gaia,, Portugal

Vila Nova de Gaia, 4405-565 Vila Nova de Gaia, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.